FRAUD ALERT: AsclepiX is aware of individuals representing job postings that are not legitimate positions. AsclepiX is NOT hiring at this time.
AsclepiX Therapeutics is a clinical-stage biopharmaceutical company leveraging computational biology from Johns Hopkins to identify and develop peptides for improved treatments of retinal diseases. Our lead candidate, AXT107, inhibits pro-angiogenic vascular endothelial growth factor receptor 2 (VEGFR2) and activates the vessel stabilizing receptor tyrosine kinase (Tie2), the two validated pathways for the treatment of retinal vascular diseases.
Company Details
- Employees
- 8
- Address
- 301 West 29th Street,
- Phone
- 410-657-2627
- in****@****pix.com
- Industry
- Biotechnology
- Website
- asclepix.com
- Keywords
- biotechnology, therapeutics, peptides, ophthalmology, wet age-related macular degeneration, diabetic macular edema.
- HQ
- Baltimore, Maryland
Asclepix Therapeutics Questions
Asclepix Therapeutics's helpline number is 410-657-2627
Asclepix Therapeutics's website is asclepix.com
Asclepix Therapeutics's LinkedIn profile is https://www.linkedin.com/company/asclepix-therapeutics-llc
Asclepix Therapeutics has
8 employees.
View email and phone details for 8
employees at Asclepix Therapeutics.
Asclepix Therapeutics's industry is
Biotechnology
Asclepix Therapeutics's top competitors are
Click Therapeutics, Inc.,
Oncovalent Therapeutics,
Neurotech Pharmaceuticals, Inc.,
Rna Therapeutics And Oligonucleotides,
Elixirgen Therapeutics, Inc.,
Vita Therapeutics,
Xontogeny,
Aratana Therapeutics Inc.,
Iveena,
Asklepion Pharmaceuticals Llc.
Asclepix Therapeutics's support email address is info@asclepix.com
Asclepix Therapeutics's categories are Biotechnology
